MSI-high Colorectal Cancer
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
Prevalence
135.0 / 100K
Incidence
36.0 / 100K/yr
1 drug in development·1 company·0 clinical trials
Drug Pipeline by Phase
Phase 2/Phase 3(1)
Frequently asked questions
How many drugs are in development for MSI-high Colorectal Cancer?
BioSniper tracks 1 drug in development for MSI-high Colorectal Cancer across 1 company.
What is the prevalence of MSI-high Colorectal Cancer?
The estimated prevalence of MSI-high Colorectal Cancer is approximately 135.0 per 100,000 population.
Deep-dive into MSI-high Colorectal Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis